UKALL60+: identifying the standard of care for elderly patients with ALL
The pivotal ZUMA-1 trial for NHL
Ibrutinib and FCR chemoimmunotherapy: improving complete remission in CLL patients?
The GALLIUM study
BH3 mimetics as potential treatment for AML